Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Treatment with psychedelics is psychotherapy: beyond reductionism
Gerhard Gründer, Manuela Brand, Lea J. Mertens, et al.
The Lancet Psychiatry (2023) Vol. 11, Iss. 3, pp. 231-236
Closed Access | Times Cited: 42
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
James Melrose
Antioxidants (2023) Vol. 12, Iss. 3, pp. 663-663
Open Access | Times Cited: 40
Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts
Alexsandra Kovacevich, Ian Dorney, Lukas Bobak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-6
Closed Access | Times Cited: 1
Canalization and plasticity in psychopathology
Robin Carhart‐Harris, Shamil Chandaria, David Erritzøe, et al.
Neuropharmacology (2022) Vol. 226, pp. 109398-109398
Open Access | Times Cited: 66
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 35
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J. Murphy, Rachael L. Sumner, William J. Evans, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 6, pp. 511-521
Open Access | Times Cited: 27
Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors
Isabel Werle, Laura Maria Martins Nascimento, A. Santos, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 11, pp. 1671-1689
Closed Access | Times Cited: 14
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 13
Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways
Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102211-102211
Closed Access | Times Cited: 13
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain
Orr Shahar, Alexander Botvinnik, Amit Shwartz, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 7, pp. 2059-2073
Open Access | Times Cited: 13
Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin
Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 1, pp. 57-66
Open Access | Times Cited: 11
1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review
Richard A. Glennon, Małgorzata Dukat
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1722-1745
Open Access | Times Cited: 10
Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin
Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 2, pp. e121-e132
Closed Access | Times Cited: 9
Rapid-acting antidepressant drugs modulate affective bias in rats
Justyna K. Hinchcliffe, Sarah A. Stuart, Christian M. Wood, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 729
Open Access | Times Cited: 8
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Robin J. Murphy, Kate Godfrey, Alexander D. Shaw, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice
Youge Qu, Lijia Chang, Li Ma, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173500-173500
Closed Access | Times Cited: 32
The Putative Role of Neuroinflammation in the Interaction between Traumatic Brain Injuries, Sleep, Pain and Other Neuropsychiatric Outcomes: A State-of-the-Art Review
Alberto Herrero Babiloni, Andrée‐Ann Baril, Camille Charlebois‐Plante, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1793-1793
Open Access | Times Cited: 20
Role of Psychedelics in Treatment-Resistant Depression
Shubham Kamal, Manish K. Jha, Rajiv Radhakrishnan
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 291-305
Closed Access | Times Cited: 20
Cardiovascular safety of psychedelic medicine: current status and future directions
Agnieszka Wsół
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1362-1380
Open Access | Times Cited: 20
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Abigail E. Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 1-14
Open Access | Times Cited: 18
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective
Giulio Ruffini, Edmundo Lopez-Sola, Jakub Vohryzek, et al.
Entropy (2024) Vol. 26, Iss. 1, pp. 90-90
Open Access | Times Cited: 5
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
Yasmin Schmid, Anya K. Bershad
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 490-499
Open Access | Times Cited: 5
Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression
Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 5
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
Klemens Egger, Helena D. Aicher, Paul Cumming, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top